Morgan Stanley’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.01B | Buy |
2,586,771
+291,891
| +13% | +$123M | 0.05% | 314 |
|
|
2026
Q1 | $1.09B | Buy |
2,294,880
+100,358
| +5% | +$50.5M | 0.07% | 262 |
|
|
2025
Q4 | $1.02B | Buy |
2,194,522
+64,630
| +3% | +$30M | 0.06% | 282 |
|
|
2025
Q3 | $908M | Sell |
2,129,892
-100,700
| -5% | -$39M | 0.06% | 314 |
|
|
2025
Q2 | $855M | Sell |
2,230,592
-29,548
| -1% | -$10.6M | 0.06% | 325 |
|
|
2025
Q1 | $781M | Sell |
2,260,140
-107,813
| -5% | -$34.7M | 0.06% | 329 |
|
|
2024
Q4 | $711M | Buy |
2,367,953
+177,594
| +8% | +$62.1M | 0.05% | 352 |
|
|
2024
Q3 | $890M | Sell |
2,190,359
-182,865
| -8% | -$67M | 0.06% | 276 |
|
|
2024
Q2 | $762M | Buy |
2,373,224
+201,405
| +9% | +$65.4M | 0.06% | 296 |
|
|
2024
Q1 | $724M | Sell |
2,171,819
-1,980,907
| -48% | -$605M | 0.06% | 308 |
|
|
2023
Q4 | $1.12B | Buy |
4,152,726
+2,002,717
| +93% | +$495M | 0.05% | 351 |
|
|
2023
Q3 | $529M | Buy |
2,150,009
+30,072
| +1% | +$8.23M | 0.05% | 345 |
|
|
2023
Q2 | $643M | Sell |
2,119,937
-31,811
| -1% | -$8.84M | 0.06% | 287 |
|
|
2023
Q1 | $567M | Sell |
2,151,748
-77,442
| -3% | -$19.7M | 0.06% | 305 |
|
|
2022
Q4 | $535M | Buy |
2,229,190
+758,127
| +52% | +$170M | 0.06% | 322 |
|
|
2022
Q3 | $270M | Sell |
1,471,063
-119,037
| -7% | -$23.7M | 0.04% | 466 |
|
|
2022
Q2 | $267M | Buy |
1,590,100
+899,047
| +130% | +$193M | 0.03% | 484 |
|
|
2022
Q1 | $173M | Sell |
691,053
-47,794
| -6% | -$12M | 0.02% | 582 |
|
|
2021
Q4 | $190M | Buy |
738,847
+162,412
| +28% | +$39.7M | 0.02% | 589 |
|
|
2021
Q3 | $140M | Sell |
576,435
-2,451
| -0.4% | -$599K | 0.02% | 664 |
|
|
2021
Q2 | $120M | Buy |
578,886
+100,929
| +21% | +$20.6M | 0.02% | 753 |
|
|
2021
Q1 | $90M | Buy |
477,957
+53,610
| +13% | +$9.45M | 0.01% | 807 |
|
|
2020
Q4 | $69.8M | Buy |
424,347
+58,798
| +16% | +$8.6M | 0.01% | 890 |
|
|
2020
Q3 | $45.6M | Buy |
365,549
+29,148
| +9% | +$3.61M | 0.01% | 944 |
|
|
2020
Q2 | $32.6M | Sell |
336,401
-168,432
| -33% | -$17.5M | 0.01% | 1088 |
|
|
2020
Q1 | $45.4M | Buy |
504,833
+9,407
| +2% | +$1.22M | 0.01% | 777 |
|
|
2019
Q4 | $73.2M | Buy |
495,426
+93,534
| +23% | +$12.6M | 0.02% | 741 |
|
|
2019
Q3 | $48.4M | Buy |
401,892
+105,742
| +36% | +$13.7M | 0.01% | 876 |
|
|
2019
Q2 | $40M | Sell |
296,150
-799,332
| -73% | -$101M | 0.01% | 972 |
|
|
2019
Q1 | $143M | Buy |
1,095,482
+695,746
| +174% | +$93.4M | 0.04% | 428 |
|
|
2018
Q4 | $49.7M | Buy |
399,736
+19,492
| +5% | +$2.62M | 0.01% | 817 |
|
|
2018
Q3 | $52.9M | Buy |
380,244
+83,480
| +28% | +$10.4M | 0.01% | 932 |
|
|
2018
Q2 | $30.4M | Sell |
296,764
-210,750
| -42% | -$21.3M | 0.01% | 1249 |
|
|
2018
Q1 | $49.2M | Sell |
507,514
-721,206
| -59% | -$70M | 0.01% | 929 |
|
|
2017
Q4 | $108M | Sell |
1,228,720
-572,711
| -32% | -$46M | 0.03% | 554 |
|
|
2017
Q3 | $143M | Sell |
1,801,431
-873,827
| -33% | -$70.3M | 0.04% | 413 |
|
|
2017
Q2 | $233M | Buy |
2,675,258
+1,488,260
| +125% | +$126M | 0.07% | 293 |
|
|
2017
Q1 | $106M | Buy |
1,186,998
+404,599
| +52% | +$33.7M | 0.03% | 544 |
|
|
2016
Q4 | $57.9M | Sell |
782,399
-592,193
| -43% | -$44.4M | 0.02% | 800 |
|
|
2016
Q3 | $104M | Buy |
1,374,592
+32,213
| +2% | +$2.47M | 0.04% | 514 |
|
|
2016
Q2 | $103M | Buy |
1,342,379
+62,302
| +5% | +$4.92M | 0.04% | 494 |
|
|
2016
Q1 | $99.9M | Sell |
1,280,077
-820,411
| -39% | -$57.3M | 0.04% | 472 |
|
|
2015
Q4 | $142M | Sell |
2,100,488
-309,065
| -13% | -$21.6M | 0.05% | 381 |
|
|
2015
Q3 | $186M | Sell |
2,409,553
-32,269
| -1% | -$2.86M | 0.07% | 304 |
|
|
2015
Q2 | $222M | Buy |
2,441,822
+387,315
| +19% | +$31M | 0.08% | 290 |
|
|
2015
Q1 | $155M | Sell |
2,054,507
-318,187
| -13% | -$22.9M | 0.06% | 363 |
|
|
2014
Q4 | $174M | Buy |
2,372,694
+213,994
| +10% | +$15M | 0.06% | 330 |
|
|
2014
Q3 | $152M | Buy |
2,158,700
+140,968
| +7% | +$9.32M | 0.06% | 360 |
|
|
2014
Q2 | $114M | Buy |
2,017,732
+95,290
| +5% | +$5.03M | 0.04% | 467 |
|
|
2014
Q1 | $101M | Buy |
1,922,442
+237,660
| +14% | +$11.8M | 0.04% | 471 |
|
|
2013
Q4 | $80.4M | Buy |
1,684,782
+599,673
| +55% | +$27.7M | 0.03% | 529 |
|
|
2013
Q3 | $46.4M | Sell |
1,085,109
-284,022
| -21% | -$11.1M | 0.02% | 724 |
|
|
2013
Q2 | $49.4M | Buy |
+1,369,131
| New | +$53M | 0.02% | 660 |
|
Other funds holding HCA
Morgan Stanley's HCA Position: Q2 2026 in Review
Morgan Stanley increased its HCA Healthcare (HCA) stake by 13% in Q2 2026, buying an estimated $123M and bringing the position to 2,586,771 shares worth $1.01B. The position accounts for 0.05% of the portfolio, ranked #314.
Morgan Stanley first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.12B in Q4 2023. 1,331 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Morgan Stanley held 2,586,771 shares of HCA Healthcare worth $1.01B as of Q2 2026.
- Morgan Stanley bought 291,891 HCA Healthcare shares in Q2 2026, an estimated $123M.
- HCA Healthcare made up 0.05% of Morgan Stanley's portfolio in Q2 2026, its #314 holding.
- Morgan Stanley first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
- Morgan Stanley's HCA Healthcare position peaked at $1.12B in Q4 2023.
- 1,331 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.